The Potential of Non‐invasive Neurostimulation, tDCS for Cognitive Decline in Alzheimer’s Disease: Through the Lens of an Ongoing Clinical Trial
There is preliminary evidence on the potential of tDCS for symptom management in AD. Our study will expand the understanding of the long-term benefits of tDCS in AD. If effective, this non-pharmacological intervention could become an important strategy for symptom management in AD patients.
Authors
- Helena Knotková (ORCID: https://orcid.org/0000-0002-4459-5451)
- Mairim Melecio-Vázquez (ORCID: https://orcid.org/0009-0007-1060-3760)
- Jessica Zwerling (ORCID: https://orcid.org/0000-0003-3286-3225)
- Erica Weiss
- Maria Laura Taranto
- Joe Verghese (ORCID: https://orcid.org/0000-0003-4252-2547)
- Kevin Ha (ORCID: https://orcid.org/0000-0001-5746-4365)
- Emmeline Ayers (ORCID: https://orcid.org/0000-0002-5061-3708)
- Helena M. Blumen (ORCID: https://orcid.org/0000-0002-0275-6616)
- Idhaliz Flores (ORCID: https://orcid.org/0000-0003-2130-4508)
- Jordan VanZyl
- Ivan Zhen
Institutions
- Albert Einstein College of Medicine (US)
- Montefiore Medical Center (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.087482
- Citations
- 1
- Primary Topic
- Transcranial Magnetic Stimulation Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.25